ロード中...
Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma
Metallothionein-3 has poorly characterized functions in neuroblastoma. Cisplatin-based chemotherapy is a major regimen to treat neuroblastoma, but its clinical efficacy is limited by chemoresistance. We investigated the impact of human metallothionein-3 (hMT3) up-regulation in neuroblastoma cells an...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7943580/ https://ncbi.nlm.nih.gov/pubmed/33750814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-84185-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|